BrainQ, an Israeli stroke therapy technology company, closed a funding round worth $40 million. Hanaco Ventures led the raise in addition to Dexcel Pharma, Peregrine Ventures and the company’s existing investors.
These funds bring BrainQ’s total amount raised to over $50 million, according to the announcement.
WHAT IT DOES
BrainQ’s technology uses AI to deliver electromagnetic field therapy to...
SPAC rumors pan out. Just a few weeks after rumors spread of Sharecare's upcoming merger with a special purpose acquisition company (SPAC), the patient-engagement and benefits-navigation platform made it official with an announcement on Friday.
Sharecare will be merging with Falcon Capital Acquisition and listing on NASDAQ. The deal is set to be funded through $345 million in cash in trust from...
Jerusalem, Israel-based BrainQ has raised $5.3 million in its latest funding rounding, bringing the digital neurodisorder therapy company’s total funding to $8.8 million. Participants in the round included Qure Ventures, OurCrowd.com, Norma Investments, IT-Farm, and other angel investors.
The company is working on technology that identifies high resolution spectral patterns in brain waves. With...
